Based on several characteristics of WT1, such as its therapeutic efficacy, specificity, immunogenic activity, role in tumor progression, the presence of a high number of positive WT1 antigens, and expression of WT1 by cells, the National Cancer Institute (NCI) has ranked this antigen as the top antigen for use as a vaccine [87]. Here, WT1 is linked to neoplasm.